Search Results
Acute Myeloid Leukemia with Actinium Pharmaceuticals (NYSE: ATNM)
What is Acute Myeloid Leukemia?
Actinium Pharmaceuticals (NYSE: ATNM) SIERRA Trial Study
Actinium Pharmaceuticals, Inc.– Leading the next revolution in targeted radiotherapy.
Actinium Pharma (ATNM) Receives Positive Scientific Advice from EMA for Iomab-B
Can older Refractory/Relapsed AML Patients Undergo Successful BMT without Entering CR First?
Actinium Pharmaceuticals | Focused on Improving Cancer Patient Outcomes
Actinium Pharmaceuticals (ATNM) NobleCon18 Presentation Replay
SIERRA Phase 3 Trial Update
Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial
SIERRA Trial Delivers Initial Data for Older Patients With AML
Actinium is developing targeted therapy with radiolabeled antibodies for the treatment of cancer
